Compliance under 57(5) as on 30th September 2025
Compliance-57 (5): intimation after the end of quarter
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Transgene Biotek Limited on 6ix
Earlier from Transgene Biotek
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Transgene Biotek Limited. Press Release Oct 11 2025
- Statement Of Deviation & Variation
- Transgene Biotek Limited. Press Release Sep 24 2025
- Closure of Trading Window
Later from Transgene Biotek
- Compliance-57 (4): Prior intimation to the beginning of the quarter
- Transgene Biotek Limited. Press Release Oct 12 2025
- Declaration Under Clause 36 Of Listing Agreement With BSE - Intimation About The Filing At NCLT (Hyderabad) Bench By M/S BABAJI NETHRALAYYA PRIVATE LTD
- Transgene Biotek Limited. Press Release Oct 17 2025
- Board Meeting Intimation for Intimation Of The Board Meeting To Be Held On Friday, 14Th November, 2025
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek